APA

Pittock S. J., Reindl M., Achenbach S., Berger T., Bruck W., Konig F., Morales Y., Lassmann H., Bryant S., Moore S. B., Keegan B. M. & Lucchinetti C. F. (20070327). Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations. : Multiple sclerosis (Houndmills, Basingstoke, England).

Chicago

Pittock S J, Reindl M, Achenbach S, Berger T, Bruck W, Konig F, Morales Y, Lassmann H, Bryant S, Moore S B, Keegan B M and Lucchinetti C F. 20070327. Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations. : Multiple sclerosis (Houndmills, Basingstoke, England).

Harvard

Pittock S. J., Reindl M., Achenbach S., Berger T., Bruck W., Konig F., Morales Y., Lassmann H., Bryant S., Moore S. B., Keegan B. M. and Lucchinetti C. F. (20070327). Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations. : Multiple sclerosis (Houndmills, Basingstoke, England).

MLA

Pittock S J, Reindl M, Achenbach S, Berger T, Bruck W, Konig F, Morales Y, Lassmann H, Bryant S, Moore S B, Keegan B M and Lucchinetti C F. Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations. : Multiple sclerosis (Houndmills, Basingstoke, England). 20070327.